177 related articles for article (PubMed ID: 33932111)
21. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
[TBL] [Abstract][Full Text] [Related]
22. Expression profile of MAGI2 gene as a novel biomarker in combination with major deregulated genes in prostate cancer.
Mahdian R; Nodouzi V; Asgari M; Rezaie M; Alizadeh J; Yousefi B; Shahrokh H; Abolhasani M; Nowroozi M
Mol Biol Rep; 2014 Sep; 41(9):6125-31. PubMed ID: 24985972
[TBL] [Abstract][Full Text] [Related]
23. The role of PIM1/PIM2 kinases in tumors of the male reproductive system.
Jiménez-García MP; Lucena-Cacace A; Robles-Frías MJ; Narlik-Grassow M; Blanco-Aparicio C; Carnero A
Sci Rep; 2016 Nov; 6():38079. PubMed ID: 27901106
[TBL] [Abstract][Full Text] [Related]
24. Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics.
Udager AM; DeMarzo AM; Shi Y; Hicks JL; Cao X; Siddiqui J; Jiang H; Chinnaiyan AM; Mehra R
Prostate; 2016 Jun; 76(9):845-53. PubMed ID: 27159573
[TBL] [Abstract][Full Text] [Related]
25. The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies.
Berg KD
Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910803
[TBL] [Abstract][Full Text] [Related]
26. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
[TBL] [Abstract][Full Text] [Related]
27. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
[TBL] [Abstract][Full Text] [Related]
28. Wnt receptor Frizzled 8 is a target of ERG in prostate cancer.
Chakravarthi BVSK; Chandrashekar DS; Hodigere Balasubramanya SA; Robinson AD; Carskadon S; Rao U; Gordetsky J; Manne U; Netto GJ; Sudarshan S; Palanisamy N; Varambally S
Prostate; 2018 Dec; 78(16):1311-1320. PubMed ID: 30051493
[TBL] [Abstract][Full Text] [Related]
29. C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer?
Boldrini L; Bartoletti R; Giordano M; Manassero F; Selli C; Panichi M; Galli L; Farci F; Faviana P
Pathol Oncol Res; 2019 Oct; 25(4):1423-1429. PubMed ID: 30357756
[TBL] [Abstract][Full Text] [Related]
30. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
[TBL] [Abstract][Full Text] [Related]
31. MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.
Baena-Del Valle JA; Zheng Q; Esopi DM; Rubenstein M; Hubbard GK; Moncaliano MC; Hruszkewycz A; Vaghasia A; Yegnasubramanian S; Wheelan SJ; Meeker AK; Heaphy CM; Graham MK; De Marzo AM
J Pathol; 2018 Jan; 244(1):11-24. PubMed ID: 28888037
[TBL] [Abstract][Full Text] [Related]
32. Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.
Wang J; Anderson PD; Luo W; Gius D; Roh M; Abdulkadir SA
Oncogene; 2012 Apr; 31(14):1794-803. PubMed ID: 21860423
[TBL] [Abstract][Full Text] [Related]
33. PIM1 kinase as a target in prostate cancer: roles in tumorigenesis, castration resistance, and docetaxel resistance.
Holder SL; Abdulkadir SA
Curr Cancer Drug Targets; 2014; 14(2):105-14. PubMed ID: 24274399
[TBL] [Abstract][Full Text] [Related]
34. PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.
Bismar TA; Yoshimoto M; Vollmer RT; Duan Q; Firszt M; Corcos J; Squire JA
BJU Int; 2011 Feb; 107(3):477-85. PubMed ID: 20590547
[TBL] [Abstract][Full Text] [Related]
35. A regulatory circuit HP1γ/miR-451a/c-Myc promotes prostate cancer progression.
Chang C; Liu J; He W; Qu M; Huang X; Deng Y; Shen L; Zhao X; Guo H; Jiang J; Fu XY; Huang R; Zhang D; Yan J
Oncogene; 2018 Jan; 37(4):415-426. PubMed ID: 28967902
[TBL] [Abstract][Full Text] [Related]
36. Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer.
Valdman A; Fang X; Pang ST; Ekman P; Egevad L
Prostate; 2004 Sep; 60(4):367-71. PubMed ID: 15264249
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer.
Ylipää A; Kivinummi K; Kohvakka A; Annala M; Latonen L; Scaravilli M; Kartasalo K; Leppänen SP; Karakurt S; Seppälä J; Yli-Harja O; Tammela TL; Zhang W; Visakorpi T; Nykter M
Cancer Res; 2015 Oct; 75(19):4026-31. PubMed ID: 26282172
[TBL] [Abstract][Full Text] [Related]
38. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
39. Significance of the TMPRSS2:ERG gene fusion in prostate cancer.
Wang Z; Wang Y; Zhang J; Hu Q; Zhi F; Zhang S; Mao D; Zhang Y; Liang H
Mol Med Rep; 2017 Oct; 16(4):5450-5458. PubMed ID: 28849022
[TBL] [Abstract][Full Text] [Related]
40. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 May; 36(5):3583-9. PubMed ID: 25560487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
